Skip to content
Recall Observatory FDA recall evidence

Drug product

Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623, NDC 62559-691-30.

D-0648-2020

January 07, 2020

Class II

Product summary

Firm
Appco Pharma LLC
Event
Event 84610
Status
Terminated
Classification
Class II
Quantity
1,632 bottes
Official record key
drug-enforcement:D-0648-2020

Official wording

Reason: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Code information: Batch # 1905227UE, exp. date Apr-2021 1905228UE, exp. date Apr-2021

Distribution pattern: Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Impurity N-nitrosodimethylamine (NDMA
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations